Art. 14 Directive (EU) 2001/83

In forcesince 26 Jul 2019cited 12×
1.

Only homeopathic medicinal products which satisfy all of the following conditions may be subject to a special, simplified registration procedure:

they are administered orally or externally,

no specific therapeutic indication appears on the labelling of the medicinal product or in any information relating thereto,

there is a sufficient degree of dilution to guarantee the safety of the medicinal product; in particular, the medicinal product may not contain either more than one part per 10000 of the mother tincture or more than 1/100th of the smallest dose used in allopathy with regard to active substances whose presence in an allopathic medicinal product results in the obligation to submit a doctor's prescription.

The Commission is empowered to adopt delegated acts in accordance with Article 121a amending the third indent of the first subparagraph if new scientific evidence so warrants.

At the time of registration, Member States shall determine the classification for the dispensing of the medicinal product.

2.

The criteria and rules of procedure provided for in Article 4(4), Article 17(1) and Articles 22 to 26, 112, 116 and 125 shall apply by analogy to the special, simplified registration procedure for homeopathic medicinal products, with the exception of the proof of therapeutic efficacy.

3.

The proof of therapeutic efficacy shall not be required for homeopathic medicinal products registered in accordance with paragraph 1 of this Article, or, where appropriate, admitted in accordance with Article 13(2).

The 10 that are cited most themselves, of 12.

  • Directive (EU) 2004/27Lawamends

  • Judgment of the Court (Second Chamber) of 12 May 2005. Meta Fackler KG v Bundesrepublik Deutschland.Decisioninterprets

    The questions referred for a preliminary ruling concern the interpretation of Articles 14 and 15 of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products …

    12 May 2005 · 62003CJ0444

  • Regulation (EU) 2019/1243Lawamends

  • Directive (EU) 2008/29Lawamends

  • BVerwG, EuGH-Vorlage vom 8. November 2018 - 3 C 2/17Decision

    … Enthält Art. 69 der Richtlinie 2001/83/EG abschließende Vorgaben zum zulässigen Inhalt der Packungsbeilage der in Art. 14 Abs. 1 genannten Arzneimittel oder dürfen weitere Informationen im Sinne des Art. 62 der Richtlinie 2001/83/EG …

    8 Nov 2018 · WBRE201900111

  • Judgment of the Court (Eighth Chamber) of 23 April 2020. Deutsche Homöopathie-Union (DHU) Arzneimittel GmbH & Co. KG v Bundesrepublik DeutscDecision

    In those circumstances, the Bundesverwaltungsgericht (Federal Administrative Court, Germany) decided to stay the proceedings and to refer the following questions, which are worded identically in Case C‑101/19 and Case C‑102/19, to the …

    23 Apr 2020 · 62019CJ0101

  • BVerwG, Urteil vom 1. Dezember 2016 - 3 C 14/15Decision

    … Aus Art. 14 Abs. 1 Satz 1 der Richtlinie 2001/83/EG ergebe sich nicht, dass der Verdünnungsgrad D4 ein Indiz für die Unbedenklichkeit sei. Schließlich sei das Oberverwaltungsgericht fehlerhaft davon ausgegangen, dass die Einnahme einer …

    1 Dec 2016 · WBRE201700245

  • Opinion of Mr Advocate General Bot delivered on 24 May 2007. Staat der Nederlanden v Antroposana, Patiëntenvereniging voor Antroposofische GDecision

    Secondly, Chapter 2 of Title III of Directive 2001/83, entitled ‘Specific provisions applicable to homeopathic medicinal products’, lays down a simplified registration procedure for homeopathic medicines which fulfil the conditions …

    24 May 2007 · 62006CC0084

  • Opinion of Mr Advocate General Léger delivered on 27 January 2005. Meta Fackler KG v Bundesrepublik Deutschland.Decision

    At the same time, I think I should focus my assessment on the main question to emerge from the various queries raised by the national court, that is: should Articles 14 and 15 of Directive 2001/83 be interpreted as precluding a national …

    27 Jan 2005 · 62003CC0444

  • BVerwG, EuGH-Vorlage vom 8. November 2018 - 3 C 3/17Decision

    … Enthält Art. 69 der Richtlinie 2001/83/EG abschließende Vorgaben zum zulässigen Inhalt der Packungsbeilage der in Art. 14 Abs. 1 genannten Arzneimittel oder dürfen weitere Informationen im Sinne des Art. 62 der Richtlinie 2001/83/EG …

    8 Nov 2018 · WBRE201900110